COPS6 and cancer: Furthermore, according to System for Integrative Genomic Microarray Analysis (SIGMA) evaluation, genetic loss or gain of CSN6 (mapped to 7q22.1), and amplification of the CSN6 genomic region are frequently detected in various types of cancer.